Pulse Biosciences -- SCREAMING SHORT!!!!!
Summary
- Up 688% since IPO
- No Revenue
- No Earnings
Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications which include human oncology, dermatology, aesthetics and other minimally invasive applications. Pulse Biosciences, Inc. is based in Burlingame, California.
The status of Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.
Barchart technical indicators:
- 96% technical buy signals
- Trend Spotter buy signal
- Above its 20, 50 and 100 day moving averages
- 14 new highs and up 138.24% in the last month
- Relative Strength Index 83.63%
- Technical support level at 30.48
- Recently traded at 32.20 with a 50 day moving average of 14.10
Fundamental factors:
- Market Cap $471 million
- No Revenue
- No Earnings
- No Following
- When will the bubble burst
- Read this article and decide --- might be a short opportunity
- The Street Sweeper -- Pulse Biosciences: Checking Its Pulse, Finding Nothing
Analyst's Disclosure: I/we have no positions in any stocks mentioned, but may initiate a short position in PLSE, over the next 72 hours.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.